Travere Therapeutics (TVTX) Net Cash Flow (2010 - 2026)
Travere Therapeutics (TVTX) posted Net Cash Flow of $16.77 million for Q3 2026, down 52.8% from $35.57 million a year earlier and down 40.9% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Net Cash Flow (2010 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Net Cash Flow at Travere Therapeutics was $13.07 million, down 82.0% year-over-year; for FY2025, it was $32.21 million.
- Annual Net Cash Flow shows a five-year compound annual growth rate of 6.4% (FY2020 to FY2025).
- In prior years, Travere Therapeutics' Net Cash Flow was $1.27 million in FY2024, -$256.85 million in FY2023, -$173.35 million in FY2022 and $23.93 million in FY2021 (+1.2%).
- Quarterly Net Cash Flow has run from a low of -$147.66 million in Q3 2023 to a high of $91.76 million in Q1 2022 over five years.
- According to Business Quant data, Net Cash Flow for the three prior quarters was $28.4 million (Q2 2026), -$14.61 million (Q1 2026) and -$17.48 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | -4.12 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | -3.52 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 4.21 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 2.81 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 757.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | -799.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.26 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 843.00 Mn |
| 10 | Travere Therapeutics | 4.85 Bn | 4.44 Bn | 221.70 Mn | 16.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.77 Mn |
| Jun 30, 2026 | 39.30 Mn |
| Mar 31, 2026 | -14.61 Mn |
| Dec 31, 2025 | -17.48 Mn |
| Sep 30, 2025 | 35.57 Mn |
| Jun 30, 2025 | 11.31 Mn |
| Mar 31, 2025 | 2.81 Mn |
| Dec 31, 2024 | 23.09 Mn |
| Sep 30, 2024 | 3.67 Mn |
| Jun 30, 2024 | -10.85 Mn |
| Mar 31, 2024 | -14.63 Mn |
| Dec 31, 2023 | -82.17 Mn |
| Sep 30, 2023 | -147.66 Mn |
| Jun 30, 2023 | -108.94 Mn |
| Mar 31, 2023 | 81.91 Mn |
| Dec 31, 2022 | -112.25 Mn |
| Sep 30, 2022 | -77.78 Mn |
| Jun 30, 2022 | -75.07 Mn |
| Mar 31, 2022 | 91.76 Mn |
| Dec 31, 2021 | -41.64 Mn |
API Access
Travere Therapeutics Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();